サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1512676

ビフィズス菌プロバイオティクスの世界市場：2024年～2031年

Global Bifidobacterium Probiotic Market - 2024-2031

出版日
ページ情報
英文 213 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ビフィズス菌プロバイオティクスの世界市場：2024年～2031年
出版日: 2024年07月10日
発行: DataM Intelligence
ページ情報: 英文 213 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

ビフィズス菌プロバイオティクスの世界市場は、2023年に11億米ドルに達し、2031年には19億米ドルに達し、予測期間2024-2031年にCAGR 8.8%で成長すると予測されています。

腸内健康の重要性と、その維持におけるビフィズス菌を含むプロバイオティクスの役割に対する消費者の意識が高まっています。このような意識の高まりが、さまざまな層でプロバイオティクス製品に対する需要を促進し、市場の成長を後押ししています。メーカー各社は、消費者の嗜好やニーズに合わせて製品を多様化しており、プロバイオティクスを日常生活に取り入れる選択肢を消費者に提供しています。

例えば、2023年5月23日、PanTheryx社のプロバイオティクスサプリメントブランドであるTruBioticsは、女性の健康の様々な側面に対応するように調整された2つの新しいサプリメントを発表しました。これらのカプセルの製剤には、消化器系と膣の健康を促進する効能で知られるプロバイオティクス菌株が配合されています。これらの菌株のうち、ビフィドバクテリウム・アニマリス（Bifidobacterium animalis）は、消化器系の健康に役立つ有益な細菌として、最も広範に調査されている菌株のひとつです。

消費者の健康志向が高まるにつれ、アジア太平洋地域では、消化器系の健康と全身の健康をサポートするビフィドバクテリウム・プロバイオティクスを含むプロバイオティクス製品への関心が高まっています。アジア太平洋地域の企業は、プロバイオティクスの健康効果を探求し、革新的な製品を開発するために研究開発に投資しています。これには、同地域で流行している特定の健康状態に対するビフィズス菌プロバイオティクスの有効性の研究も含まれます。

ダイナミクス

腸の健康に対する消費者の意識の高まり

全身の健康のために腸内マイクロバイオームを健康に保つことの重要性を認識する人が増えるにつれ、ビフィズス菌を含むプロバイオティクスサプリメントや食品に対する需要が高まっています。このような意識の高まりにより、消費者は消化器系の健康を改善し、免疫力を高め、総合的な健康を増進する製品を求めるようになり、市場が拡大しています。

ビフィズス菌プロバイオティクスのメリットについて消費者を啓蒙する企業のマーケティング活動も重要な役割を果たしています。腸の健康に対するプラスの効果を強調することで、こうしたキャンペーンはより多くの顧客層を引き付けています。その結果、ビフィズス菌プロバイオティクスの世界市場は、情報通で健康志向の消費者層によって大きな成長を遂げています。

例えば、2023年10月10日、主食であるポッピング・キャンディーの製造ノウハウで知られる広東省のある企業は、栄養価を高める機能性成分を取り入れることで製品ラインを革新しました。同社は、ビタミンCとプロバイオティクス、特にビフィドバクテリウムを配合した新シリーズのキャンディーを競合市場に投入しました。

同社は伝統的にポッピング・キャンディで知られているが、その製造技術を活用し、健康を促進する成分を豊富に含んだ斬新なキャンディ体験を創造しています。ビタミンCとビフィズス菌のプロバイオティクスをキャンディに配合することで、消費者に便利で楽しい方法で免疫力を高め、消化器系の健康をサポートすることを目指しています。

高まるナチュラルオーガニック志向

天然・有機製品への嗜好の高まりは、世界のビフィズス菌プロバイオティクス市場を牽引する主要因です。消費者がより健康的で持続可能な選択肢を求めるようになるにつれ、腸の健康を増進するためにナチュラルオーガニック・プロバイオティクスに注目するようになっています。この動向は特に、合成添加物や保存料を含まない製品を好む健康志向の強い人々の間で強いです。

こうした需要に応えるため、新興国市場のメーカー各社は、ナチュラル・オーガニック基準に適合したビフィズス菌プロバイオティクスの開発に注力しています。このシフトは幅広い顧客層を引きつけているだけでなく、市場の革新と製品の多様化をも促しています。その結果、天然・有機製品への嗜好が世界のビフィズス菌プロバイオティクス市場の拡大と成長に大きく寄与しています。

例えば、2022年4月28日、中国の酪農大国Yiliは、進化する消費者の嗜好に対応する革新的な製品のイントロダクション焦点を当てた最新の製品発売戦略を開始しました。これらの戦略の中には、プロバイオティクスとGABAを主成分とする固形飲料のデビューも含まれています。Yili社は、ヨーグルト、チーズ、アイスクリームなどのプロバイオティクス入り製品を中心に、乳製品市場で確固たる地位を築いてきたが、固形飲料への新たな進出は、製品ポートフォリオの戦略的拡大を意味します。

厳しい規制の枠組み

厳しい規制の枠組みは、世界のビフィズス菌プロバイオティクス市場の大きな抑制要因となっています。各地域の規制機関は、安全性と有効性を確保するため、プロバイオティクス製品の承認、表示、マーケティングに厳格なガイドラインを課しています。これらの規制はしばしば、健康強調表示を立証するための大規模な臨床試験や科学的根拠を要求することがあり、メーカーにとってはコストと時間がかかります。

その結果、中小企業は参入障壁に直面し、市場で実績のある企業でさえ、製品発売の遅れやコンプライアンス・コストの増加に見舞われる可能性があります。このような規制上の負担は、ビフィズス菌プロバイオティクスの新製品が市場に投入されるスピードを制限し、消費者が入手できる製品の種類を減らすことにもなりかねないです。厳しい規制の枠組みは重大な制約として機能し、世界のビフィズス菌プロバイオティクス市場の成長と拡大に影響を与えています。

例えば、2023年12月27日、規制当局は最近、壊死性腸炎を予防するための院内治療の一環としてMCTオイル入りプロバイオティクスEvivo（Infinant Health社）の治療を受けた早産児に関する有害事象報告を受けた。悲劇的なことに、エビボ投与後、患者は敗血症を発症し、その原因はエビボに含まれるビフィドバクテリウム・ロンガム菌でした。この事件は、早産児が病気の予防措置として販売されたプロバイオティクスを投与された後に有害事象を経験したいくつかの報告例のうちのひとつです。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 腸の健康に対する消費者の意識の高まり
      • ナチュラルオーガニック製品への嗜好の高まり
    • 抑制要因
      • 厳しい規制の枠組み
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争影響分析
  • DMIの見解

第6章 COVID-19分析

第7章 タイプ別

  • ビフィドバクテリウム・アニマリス
  • ビフィドバクテリウム・ロンガム
  • ビフィズス菌
  • その他

第8章 形態別

  • 乾燥
  • 液体

第9章 用途別

  • 飲食品
  • 栄養補助食品
  • 医薬品
  • 動物飼料
  • その他

第10章 エンドユーザー別

  • 乳幼児
  • 成人
  • 小児
  • 動物

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • ロシア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第13章 企業プロファイル

  • DuPont
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Goerlich Pharma GmbH
  • Mitushi Bio Pharma
  • Chr. Hansen Holding A/S
  • Probi AB
  • Lallemand Inc.
  • Novozymes A/S
  • Danone Corp
  • Nestle S.A.
  • Yakult Honsha Co., Ltd.

第14章 付録

目次
Product Code: FB8523

Overview

Global Bifidobacterium Probiotic Market reached US$ 1.1 billion in 2023 and is expected to reach US$ 1.9 billion by 2031, growing with a CAGR of 8.8% during the forecast period 2024-2031.

There is increasing awareness among consumers about the importance of gut health and the role of probiotics, including bifidobacterium, in maintaining it. This heightened awareness is driving demand for probiotic products across various demographics, fueling market growth. Manufacturers are diversifying their product offerings to cater to different consumer preferences and needs, providing consumers with more options to incorporate probiotics into their daily routines.

For instance, on May 23, 2023, PanTheryx's probiotic supplements brand, TruBiotics, introduced two new supplements tailored to address various aspects of women's health. The formulation of these capsules includes a combination of probiotic strains known for their efficacy in promoting digestive and vaginal health. Among these strains is Bifidobacterium animalis, recognized as one of the most extensively researched beneficial bacteria for digestive well-being.

As consumers become more health-conscious, there is a growing interest in probiotic products, including bifidobacterium probiotics, to support digestive health and overall well-being in the Asia-Pacific. Companies in the Asia-Pacific region are investing in research and development to explore the health benefits of probiotics and develop innovative products. This includes studying the efficacy of bifidobacterium probiotics in addressing specific health conditions prevalent in the region.

Dynamics

Increasing Consumer Awareness About Gut Health

As more people recognize the importance of maintaining a healthy gut microbiome for overall well-being, there is a growing demand for probiotic supplements and foods that contain bifidobacterium. This heightened awareness is prompting consumers to seek out products that can improve digestive health, boost immunity, and enhance overall wellness, thus expanding the market.

Marketing efforts by companies to educate consumers about the benefits of bifidobacterium probiotics are also playing a crucial role. By highlighting the positive effects on gut health, these campaigns are attracting a larger customer base. As a result, the global bifidobacterium probiotic market is experiencing significant growth, driven by an informed and health-conscious consumer population.

For instance, on October 10, 2023, A Guangdong-based company, known for its expertise in producing popping candy as a staple food item, innovated its product line by incorporating functional ingredients to enhance nutritional value. The company has introduced a new range of candy infused with vitamin C and probiotics, specifically Bifidobacterium in the competitive market.

Traditionally recognized for its popping candy offerings, the company is leveraging its manufacturing techniques to create a novel candy experience enriched with health-promoting ingredients. By incorporating vitamin C and Bifidobacterium probiotics into the candy formulation, the company aims to provide consumers with a convenient and enjoyable way to boost their immune system and support digestive health.

Growing Preference for Natural and Organic Products

The growing preference for natural and organic products is a major factor driving the global bifidobacterium probiotic market. As consumers increasingly seek healthier and more sustainable options, they are turning to natural and organic probiotics to enhance their gut health. This trend is particularly strong among health-conscious individuals who prefer products free from synthetic additives and preservatives.

In response to this demand, manufacturers in the market are focusing on developing bifidobacterium probiotics that align with natural and organic standards. This shift is not only attracting a broader customer base but also encouraging innovation and product diversification within the market. Consequently, the preference for natural and organic products is significantly contributing to the expansion and growth of the global bifidobacterium probiotic market.

For instance, on April 28, 2022, China's dairy powerhouse, Yili, launched its latest product launch strategies, focusing on the introduction of innovative offerings to meet evolving consumer preferences. Among these strategies is the debut of a solid beverage enriched with probiotics and GABA as its primary ingredients. While Yili has established a strong presence in the dairy market, particularly with probiotic-infused products like yogurt, cheese, and ice cream, this new venture into solid beverages marks a strategic expansion of its product portfolio.

Stringent Regulatory Frameworks

Stringent regulatory frameworks are a significant restraint on the global bifidobacterium probiotic market. Regulatory bodies across different regions impose strict guidelines on the approval, labeling, and marketing of probiotic products to ensure safety and efficacy. These regulations often require extensive clinical trials and scientific evidence to substantiate health claims, which can be costly and time-consuming for manufacturers.

As a result, smaller companies face barriers to entry, and even established players in the market might experience delays in product launches and additional compliance costs. This regulatory burden can limit the speed at which new bifidobacterium probiotic products are brought to market and can also reduce the variety of products available to consumers. Stringent regulatory frameworks act as a significant constraint, impacting the growth and expansion of the global bifidobacterium probiotic market.

For instance, on December 27, 2023, The regulatory agency recently received a concerning adverse event report concerning a preterm infant who received treatment with the probiotic Evivo with MCT Oil (Infinant Health) as part of in-hospital care to prevent necrotizing enterocolitis. Tragically, following the administration of Evivo, the patient developed sepsis, attributed to the bacterium Bifidobacterium longum present in Evivo, and subsequently succumbed. This incident is among several reported cases where preterm infants experienced adverse events after receiving probiotics marketed as preventive measures against the disease.

Segment Analysis

The global bifidobacterium probiotic market is segmented based on type, form, application, end-user, and region.

Growing Innovations and Consumer Preference for Bifidobacterium longum

Consumers are increasingly seeking out probiotic products containing specific strains like Bifidobacterium longum due to their perceived health benefits and efficacy. This consumer preference drives demand for products containing this strain, contributing to its dominant position in the market. Bifidobacterium longum is commonly used in a variety of probiotic products. Its versatility and proven efficacy make it an attractive option for manufacturers looking to develop probiotic formulations to meet diverse consumer needs.

Bifidobacterium longum is one of the most extensively studied probiotic strains, with numerous clinical studies supporting its efficacy in promoting gut health and overall well-being. This robust scientific evidence enhances consumer confidence in the effectiveness of products containing Bifidobacterium longum, driving market demand. Companies often highlight the inclusion of Bifidobacterium longum in their products as a key selling point, leveraging its well-established reputation and positive consumer perception to drive sales and capture market share.

Geographical Penetration

Strong Tradition of Fermented Foods and Investments in Asia-Pacific

The Asia-Pacific region has a significant portion of the world's population, including densely populated countries like China and India. Many countries in the Asia-Pacific region have a long tradition of consuming fermented foods like yogurt, kimchi, and miso, which naturally contain probiotics. This cultural familiarity with probiotic-rich foods contributes to the growing acceptance and demand for bifidobacterium probiotics in the region.

Governments, academic institutions, and private companies in the Asia-Pacific region are investing heavily in research and development to explore the health benefits of probiotics and develop innovative products. This focus on innovation and product development is driving market growth and strengthening the region's position in the global bifidobacterium probiotic market.

COVID-19 Impact Analysis

The COVID-19 pandemic had a notable impact on the global bifidobacterium probiotic market. During the pandemic, there was a heightened focus on health and wellness, leading to increased consumer interest in products that support immune function and overall health, including bifidobacterium probiotics. This surge in demand positively influenced the market, as more individuals sought probiotics to boost their immunity and maintain gut health during a time of increased health awareness.

However, the market also faced challenges due to COVID-19. Supply chain disruptions and logistical issues caused delays in the production and distribution of probiotic products. Additionally, economic uncertainties led to cautious consumer spending, affecting the market's growth rate. Despite these challenges, the overall impact of COVID-19 has been a renewed emphasis on preventive health measures, which is likely to sustain the market's growth in the long term as consumers continue to prioritize their health post-pandemic.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine war has indirect effects on the global bifidobacterium probiotic market due to potential disruptions in the supply chain and geopolitical instability. Ukraine is a significant producer of grains, including wheat, which is a key ingredient in animal feed. Bifidobacterium probiotics are commonly used in animal feed to promote gut health and improve overall livestock health.

Disruptions in the Ukrainian grain market could lead to fluctuations in feed prices, affecting the livestock industry worldwide. This, in turn, may impact the demand for bifidobacterium probiotics, as farmers adjust their purchasing decisions based on feed costs. Geopolitical tensions and economic sanctions imposed on Russia and Ukraine could disrupt trade routes and distribution channels for bifidobacterium probiotic products.

By Type

  • Bifidobacterium animalis
  • Bifidobacterium longum
  • Bifidobacterium bifidum
  • Others

By Form

  • Dry
  • Liquid

By Application

  • Food & Beverages
  • Dietary Supplements
  • Pharmaceuticals
  • Animal Feed
  • Others

By End-User

  • Infants
  • Adults
  • Children
  • Animals

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • On January 30, 2023, Nissin Foods Group, announced the launch of Foods with Function Claims (FFCs) featuring lactic acid bacteria for the first time. This innovative move reflects the company's commitment to staying at the forefront of evolving consumer preferences and trends, particularly in the realm of gut health and the gut-brain axis.
  • On March 1, 2021, Bayer expanded its portfolio beyond gastrointestinal relief to address overall gut health with the introduction of two new probiotic products. Developed in collaboration with China's Jiangnan University, these probiotics are specifically formulated to target common gastrointestinal issues, including constipation and diarrhea.
  • On June 16, 2020, Yakult Japan introduced its inaugural shelf-stable probiotic supplement, marking a significant expansion in its product offerings. Packed into convenient sachets, this supplement contains two exclusive probiotic strains: the renowned lactic acid bacteria, Lactobacillus casei strain Shirota, and the beneficial bifidobacteria, Bifidobacterium breve strain Yakult.

Competitive Landscape

The major players in the global bifidobacterium probiotic market include DuPont, Goerlich Pharma GmbH, Mitushi Bio Pharma, and Chr. Hansen Holding A/S, Probi AB, Lallemand Inc., Novozymes A/S, Danone Corp, Nestle S.A., Yakult Honsha Co., Ltd.

Why Purchase the Report?

  • To visualize the global bifidobacterium probiotic market segmentation based on type, form, application, end-user, and region and understand critical commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous global streptococcus probiotic market-level data points with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of critical products of all the major players.

The global bifidobacterium probiotic market report would provide approximately 70 tables, 65 figures, and 213 users.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Form
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Consumer Awareness About Gut Health
      • 4.1.1.2. Growing Preference for Natural and Organic Products
    • 4.1.2. Restraints
      • 4.1.2.1. Stringent Regulatory Frameworks
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Bifidobacterium animalis*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Bifidobacterium longum
  • 7.4. Bifidobacterium bifidum
  • 7.5. Others

8. By Form

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2. Market Attractiveness Index, By Form
  • 8.2. Dry*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Liquid

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Food & Beverages*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Dietary Supplements
  • 9.4. Pharmaceuticals
  • 9.5. Animal Feed
  • 9.6. Others

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Infants*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Adults
  • 10.4. Children
  • 10.5. Animals

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Russia
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. DuPont*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Goerlich Pharma GmbH
  • 13.3. Mitushi Bio Pharma
  • 13.4. Chr. Hansen Holding A/S
  • 13.5. Probi AB
  • 13.6. Lallemand Inc.
  • 13.7. Novozymes A/S
  • 13.8. Danone Corp
  • 13.9. Nestle S.A.
  • 13.10. Yakult Honsha Co., Ltd.

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us